Schifferdecker KE, Vaclavik D, Wernli KJ, Buist DSM, Kerlikowske K, Sprague BL, Henderson LM, Johnson D, Budesky J, Jackson-Nefertiti G, Miglioretti DL, Tosteson ANA. Women’s considerations and experiences for breast cancer screening and surveillance during the COVID-19 pandemic in the United States: A focus group study. Prev Med. 2021 Oct;151:106542. doi: 10.1016/j.ypmed.2021.106542. Epub 2021 Jun 30. PMID: 34217409; PMCID: PMC8721569.

Sprague BL, O’Meara ES, Lee CI, Lee JM, Henderson LM, Buist DSM, Alsheik N, Macarol T, Perry H, Tosteson ANA, Onega T, Kerlikowske K, Miglioretti DL. Prioritizing breast imaging services during the COVID pandemic: A survey of breast imaging facilities within the Breast Cancer Surveillance Consortium. Prev Med. 2021 Oct;151:106540. doi: 10.1016/j.ypmed.2021.106540. Epub 2021 Jun 30. PMID: 34217424; PMCID: PMC8241650.

Advani SM, Zhu W, Demb J, Sprague BL, Onega T, Henderson LM, Buist DSM, Zhang D, Schousboe JT, Walter LC, Kerlikowske K, Miglioretti DL, Braithwaite D; Breast Cancer Surveillance Consortium. Association of Breast Density With Breast Cancer Risk Among Women Aged 65 Years or Older by Age Group and Body Mass Index. JAMA Netw Open. 2021 Aug 2;4(8):e2122810. doi: 10.1001/jamanetworkopen.2021.22810. PMID: 34436608; PMCID: PMC8391100.

Lowry KP, Bissell MCS, Miglioretti DL, Kerlikowske K, Alsheik N, Macarol T, Bowles EJA, Buist DSM, Tosteson ANA, Henderson L, Herschorn SD, Wernli KJ, Weaver DL, Stout NK, Sprague BL. Breast Biopsy Recommendations and Breast Cancers Diagnosed during the COVID-19 Pandemic. Radiology. 2022 May;303(2):287-294. doi: 10.1148/radiol.2021211808. Epub 2021 Oct 19. PMID: 34665032; PMCID: PMC8544262.

Onega T, Zhu W, Kerlikowske K, Miglioretti DL, Lee CI, Henderson LM, Tosteson ANA, Wernli KJ, diFlorio R, Weaver DL, Buist DSM. Preoperative MRI in breast cancer: effect of breast density on biopsy rate and yield. Breast Cancer Res Treat. 2022 Jan;191(1):177-190. doi: 10.1007/s10549-021-06418-x. Epub 2021 Oct 22. PMID: 34686934.

Zhang D, Abraham L, Sprague BL, Onega T, Advani S, Demb J, Miglioretti DL, Henderson LM, Wernli KJ, Walter LC, Kerlikowske K, Schousboe JT, Chrischilles E, Braithwaite D, O’Meara ES; Breast Cancer Surveillance Consortium. Mammography adherence in relation to function-related indicators in older women. Prev Med. 2022 Jan;154:106869. doi: 10.1016/j.ypmed.2021.106869. Epub 2021 Nov 9. PMID: 34762965; PMCID: PMC8724400.

Advani S, Abraham L, Buist DSM, Kerlikowske K, Miglioretti DL, Sprague BL, Henderson LM, Onega T, Schousboe JT, Demb J, Zhang D, Walter LC, Lee CI, Braithwaite D, O’Meara ES; Breast Cancer Surveillance Consortium. Breast biopsy patterns and findings among older women undergoing screening mammography: The role of age and comorbidity. J Geriatr Oncol. 2022 Mar;13(2):161-169. doi: 10.1016/j.jgo.2021.11.013. Epub 2021 Dec 9. PMID: 34896059.

Zhang D, Abraham L, Demb J, Miglioretti DL, Advani S, Sprague BL, Henderson LM, Onega T, Wernli KJ, Walter LC, Kerlikowske K, Schousboe JT, O’Meara ES, Braithwaite D; Breast Cancer Surveillance Consortium. Function-related Indicators and Outcomes of Screening Mammography in Older Women: Evidence from the Breast Cancer Surveillance Consortium Cohort. Cancer Epidemiol Biomarkers Prev. 2021 Aug;30(8):1582-1590. doi: 10.1158/1055-9965.EPI-21-0152. Epub 2021 Jun 2. PMID: 34078641; PMCID: PMC8563300.

Schousboe JT, Sprague BL, Abraham L, O’Meara ES, Onega T, Advani S, Henderson LM, Wernli KJ, Zhang D, Miglioretti DL, Braithwaite D, Kerlikowske K. Cost-Effectiveness of Screening Mammography Beyond Age 75 Years : A Cost-Effectiveness Analysis. Ann Intern Med. 2022 Jan;175(1):11-19. doi: 10.7326/M20-8076. Epub 2021 Nov 23. PMID: 34807717.

Kerlikowske K, Chen S, Golmakani MK, Sprague BL, Tive JA, Tosteson ANA, Rauscher GH, Henderson LM, Buist DSM, Lee JM, Gard CC, Miglioretti DL. Cumulative Advanced Breast Cancer Risk Prediction Model Developed in a Screening Mammography Population. N Natl Cancer Inst. 2022 Jan 13;djac008. Online ahead of print.